Carlsmed (CARL) Change in Accured Expenses (2024 - 2026)

Carlsmed (CARL) has reported Change in Accured Expenses for 3 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Accured Expenses rose 15.43% year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2026 stood at $763000.0 (down 51.59% YoY), and the FY2025 full-year result was $2.5 million, up 105.11% from the prior year.
• Change in Accured Expenses improved to $1.1 million in Q2 2026 per CARL's latest filing, from -$3.0 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $1.4 million in Q4 2025 and bottomed at -$3.0 million in Q1 2026.
• Historically, Change in Accured Expenses has averaged $292375.0 across 3 years, with a median of $1.0 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Change in Accured Expenses surged 107.85% in 2025, then slumped 169.81% in 2026.
• Over 3 years, Change in Accured Expenses stood at $650000.0 in 2024, then soared by 107.85% to $1.4 million in 2025, then slipped by 19.17% to $1.1 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $1.1 million, -$3.0 million, and $1.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.